| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Amber L Bahorik, Cynthia I Campbell, Stacy A Sterling, Amy Leibowitz, Adam Travis, Constance M Weisner, Derek D Satr. Adverse impact of marijuana use on clinical outcomes among psychiatry patients with depression and alcohol use disorder. Psychiatry research. vol 259. 2018-10-16. PMID:29100135. |
marijuana was examined as both an outcome (patterns of use) and a predictor (impact on depression and functioning). |
2018-10-16 |
2023-08-13 |
human |
| Georges Brousse, Julie Geneste-Saelens, Julien Cabe, Olivier Cottenci. [Alcohol and emergencies]. Presse medicale (Paris, France : 1983). vol 47. issue 7-8 Pt 1. 2018-09-27. PMID:30075948. |
search addictive comorbidities (tobacco and cannabis) and psychiatric comorbidities (depression and suicidal risk) must be systematic. |
2018-09-27 |
2023-08-13 |
Not clear |
| F Kazour, C Awaida, L Souaiby, S Rich. [Search association between cannabis abuse and bipolar disorder: A study on a sample of patients hospitalized for bipolar disorder]. L'Encephale. vol 44. issue 1. 2018-08-29. PMID:27745717. |
cannabis use is very frequent in bipolar disorder and has been found to increase the duration and frequency of manic symptoms while decreasing those of depression. |
2018-08-29 |
2023-08-13 |
Not clear |
| Ofir Livne, Liat Razon, Jürgen Rehm, Deborah S Hasin, Shaul Lev-Ra. The association between lifetime cannabis use and dysthymia across six birth decades. Journal of affective disorders. vol 234. 2018-08-17. PMID:29605793. |
though high rates of co-occurring cannabis use and depression are well-documented, data regarding the association between cannabis use and dysthymia is scarce. |
2018-08-17 |
2023-08-13 |
Not clear |
| Marian Wilson, Hannah Y Gogulski, Carrie Cuttler, Teresa L Bigand, Oladunni Oluwoye, Celestina Barbosa-Leiker, MaryLee A Robert. Cannabis use moderates the relationship between pain and negative affect in adults with opioid use disorder. Addictive behaviors. vol 77. 2018-07-23. PMID:29078148. |
therefore, the primary purpose of this study is to examine whether cannabis use moderates the relationships between pain and negative affect (i.e., depression and anxiety) and whether self-efficacy influences these interactions. |
2018-07-23 |
2023-08-13 |
Not clear |
| Josiane Bourque, Mohammad H Afzali, Maeve O'Leary-Barrett, Patricia Conro. Cannabis use and psychotic-like experiences trajectories during early adolescence: the coevolution and potential mediators. Journal of child psychology and psychiatry, and allied disciplines. vol 58. issue 12. 2018-06-27. PMID:28677235. |
the authors sought to model the different trajectories of psychotic-like experiences (ple) during adolescence and to examine whether the longitudinal relationship between cannabis use and ple is mediated by changes in cognitive development and/or change in anxiety or depression symptoms. |
2018-06-27 |
2023-08-13 |
Not clear |
| Isaac C Rhew, Charles B Fleming, Ann Vander Stoep, Semret Nicodimos, Cheng Zheng, Elizabeth McCaule. Examination of cumulative effects of early adolescent depression on cannabis and alcohol use disorder in late adolescence in a community-based cohort. Addiction (Abingdon, England). vol 112. issue 11. 2018-06-12. PMID:28600897. |
examination of cumulative effects of early adolescent depression on cannabis and alcohol use disorder in late adolescence in a community-based cohort. |
2018-06-12 |
2023-08-13 |
Not clear |
| Isaac C Rhew, Charles B Fleming, Ann Vander Stoep, Semret Nicodimos, Cheng Zheng, Elizabeth McCaule. Examination of cumulative effects of early adolescent depression on cannabis and alcohol use disorder in late adolescence in a community-based cohort. Addiction (Abingdon, England). vol 112. issue 11. 2018-06-12. PMID:28600897. |
this study estimated the effects of cumulative depression during early adolescence (ages 13-15 years) on the likelihood of cannabis use disorder (cud) and alcohol use disorder (aud) at age 18. |
2018-06-12 |
2023-08-13 |
Not clear |
| Lisa Dierker, Arielle Selya, Stephanie Lanza, Runze Li, Jennifer Ros. Depression and marijuana use disorder symptoms among current marijuana users. Addictive behaviors. vol 76. 2018-06-11. PMID:28843729. |
depression and marijuana use disorder symptoms among current marijuana users. |
2018-06-11 |
2023-08-13 |
Not clear |
| Eduardo Roque Butelman, Silvia Bacciardi, Angelo Giovanni Icro Maremmani, Maya Darst-Campbell, Joel Correa da Rosa, Mary Jeanne Kree. Can a rapid measure of self-exposure to drugs of abuse provide dimensional information on depression comorbidity? The American journal on addictions. vol 26. issue 6. 2018-04-02. PMID:28654734. |
poly-drug self-exposure (eg, to heroin, cocaine, cannabis, or alcohol) is also common, and may further affect depression comorbidity. |
2018-04-02 |
2023-08-13 |
Not clear |
| M Smolkina, K I Morley, F Rijsdijk, A Agrawal, J E Bergin, E C Nelson, D Statham, N G Martin, M T Lynske. Cannabis and Depression: A Twin Model Approach to Co-morbidity. Behavior genetics. vol 47. issue 4. 2018-03-22. PMID:28466235. |
cannabis and depression: a twin model approach to co-morbidity. |
2018-03-22 |
2023-08-13 |
Not clear |
| Keming Gao, Stephen J Ganocy, Carla Conroy, Brittany Brownrigg, Mary Beth Serrano, Joseph R Calabres. A placebo controlled study of quetiapine-XR in bipolar depression accompanied by generalized anxiety with and without a recent history of alcohol and cannabis use. Psychopharmacology. vol 234. issue 15. 2018-03-06. PMID:28536866. |
a placebo controlled study of quetiapine-xr in bipolar depression accompanied by generalized anxiety with and without a recent history of alcohol and cannabis use. |
2018-03-06 |
2023-08-13 |
Not clear |
| Keming Gao, Stephen J Ganocy, Carla Conroy, Brittany Brownrigg, Mary Beth Serrano, Joseph R Calabres. A placebo controlled study of quetiapine-XR in bipolar depression accompanied by generalized anxiety with and without a recent history of alcohol and cannabis use. Psychopharmacology. vol 234. issue 15. 2018-03-06. PMID:28536866. |
this study aims to compare treatment response in bipolar i or ii depression and generalized anxiety disorder (gad) with and without recent alcohol and/or cannabis use disorder (alc/can) to quetiapine-xr (extended release) or placebo. |
2018-03-06 |
2023-08-13 |
Not clear |
| Karen Hodgson, Laura Almasy, Emma E M Knowles, Jack W Kent, Joanne E Curran, Thomas D Dyer, Harald H H Göring, Rene L Olvera, Mary D Woolsey, Ravi Duggirala, Peter T Fox, John Blangero, David C Glah. The genetic basis of the comorbidity between cannabis use and major depression. Addiction (Abingdon, England). vol 112. issue 1. 2018-02-28. PMID:27517884. |
the genetic basis of the comorbidity between cannabis use and major depression. |
2018-02-28 |
2023-08-13 |
Not clear |
| Karen Hodgson, Laura Almasy, Emma E M Knowles, Jack W Kent, Joanne E Curran, Thomas D Dyer, Harald H H Göring, Rene L Olvera, Mary D Woolsey, Ravi Duggirala, Peter T Fox, John Blangero, David C Glah. The genetic basis of the comorbidity between cannabis use and major depression. Addiction (Abingdon, England). vol 112. issue 1. 2018-02-28. PMID:27517884. |
while the prevalence of major depression is elevated among cannabis users, the role of genetics in this pattern of comorbidity is not clear. |
2018-02-28 |
2023-08-13 |
Not clear |
| Karen Hodgson, Laura Almasy, Emma E M Knowles, Jack W Kent, Joanne E Curran, Thomas D Dyer, Harald H H Göring, Rene L Olvera, Mary D Woolsey, Ravi Duggirala, Peter T Fox, John Blangero, David C Glah. The genetic basis of the comorbidity between cannabis use and major depression. Addiction (Abingdon, England). vol 112. issue 1. 2018-02-28. PMID:27517884. |
this study aimed to estimate the heritability of cannabis use and major depression, quantify the genetic overlap between these two traits and localize regions of the genome that segregate in families with cannabis use and major depression. |
2018-02-28 |
2023-08-13 |
Not clear |
| Daniel Feingold, Silviu Brill, Itay Goor-Aryeh, Yael Delayahu, Shaul Lev-Ra. Depression and anxiety among chronic pain patients receiving prescription opioids and medical marijuana. Journal of affective disorders. vol 218. 2018-01-15. PMID:28453948. |
depression and anxiety among chronic pain patients receiving prescription opioids and medical marijuana. |
2018-01-15 |
2023-08-13 |
Not clear |
| José Capece, Federico Pavlovsk. [The treatment of cannabis dependence: Clinical work, psychotherapy and evidence]. Vertex (Buenos Aires, Argentina). vol XXVII. issue 130. 2018-01-09. PMID:28898308. |
identifying compulsive consumption of marijuana in association with another mental disorder (attentional defcit disorder, bipolar disorder, depression or psychosis) presents the challenge of clarifying validated therapeutic strategies, especially within the teen population, in which it shows the highest prevalence. |
2018-01-09 |
2023-08-13 |
Not clear |
| Maria M Steenkamp, Esther M Blessing, Isaac R Galatzer-Levy, Laura C Hollahan, William T Anderso. Marijuana and other cannabinoids as a treatment for posttraumatic stress disorder: A literature review. Depression and anxiety. vol 34. issue 3. 2017-12-29. PMID:28245077. |
available evidence is stronger for marijuana's harmful effects on the development of psychosis and substance misuse than for the development of depression and anxiety. |
2017-12-29 |
2023-08-13 |
human |
| Yasser A Khadrawy, Hussein G Sawie, Omar M E Abdel-Salam, Eman N Hosn. Cannabis exacerbates depressive symptoms in rat model induced by reserpine. Behavioural brain research. vol 324. 2017-12-13. PMID:28212939. |
twenty four rats were divided into: control, rat model of depression induced by reserpine and depressive-like rats treated with cannabis sativa extract (10mg/kg expressed as Δ9-tetrahydrocannabinol). |
2017-12-13 |
2023-08-13 |
rat |